Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Sirnaomics to receive HK$8 million subsidy from the HKSTP Clinical Translational Catalyst Plan 2023-05-17 21:13
Smart Home Healthcare Revenues Grow to US$26.5 Billion in 2023, Driven by the Remote Monitoring Opportunity 2023-05-17 20:30
Frost and Sullivan Institute launches Enlightened Growth Leadership Awards, 2023 for Emerging Companies Dedicated to 'Innovating to Zero'. 2023-05-17 20:16
United Imaging Unveils a Full Portfolio of Products at CMEF 2023, Highlighting Its AI Capabilities across Modalities 2023-05-17 20:00
Skyline Therapeutics Brings Multiple Data Presentations to ASGCT 2023 2023-05-17 18:00
Insilico Medicine Successfully Explores the Advantages of Quantum Generative Adversarial Networks in Generative Chemistry 2023-05-17 18:00
Parliamentarians from 23 countries call on G7 leaders to invest in neglected tropical diseases 2023-05-17 17:40
Inclusion of Recbio In the MSCI China Small Cap Index 2023-05-17 14:01
Antengene Announces NDA Submission for XPOVIO® in Indonesia 2023-05-17 08:30
Transcenta Announces Encouraging Phase I Clinical Data of TST002 (Blosozumab) in Chinese Patients with Reduced Bone Mineral Density 2023-05-17 08:17
Innovent Announces Clinical Data of Multiple Trials Will be Presented at the 2023 ASCO and EHA Annual Meetings 2023-05-17 08:00
Everest Medicines Announces Completion of Patient Enrollment in Phase 3 Clinical Trial of Etrasimod in Asia 2023-05-17 07:48
DEBIOPHARM LAUNCHES PHASE 1/2 COMBINATION TRIAL INVESTIGATING BRAIN-PENETRANT SELECTIVE WEE1 INHIBITOR FOR BRAIN CANCER PATIENTS 2023-05-17 07:00
Fresh2 Files Annual Report on Form 20-F for Fiscal Year 2022 2023-05-17 05:00
Fresh2 Reports First Quarter of Fiscal Year 2023 Financial Results 2023-05-17 04:15
Waters Corporation Completes Acquisition of Light Scattering Leader Wyatt Technology 2023-05-17 04:15
Fresh2 Reports Fiscal Year 2022 Annual Financial Results 2023-05-17 04:15
Eluminex Biosciences Receives Scientific Recognition for its Recombinant Human Collagen (rhCIII) Biosynthetic Cornea (EB-301) Program to Treat Corneal Blindness 2023-05-16 23:00
Boan Biotech's BA1202 Approved for Clinical Trial 2023-05-16 22:02
The first spring CMEF exhibition after the COVID-19 pandemic in the Chinese mainland: A brief discussion on the rise and challenges of China's domestic medical apparatus from Diagens Biotechnology 2023-05-16 21:39
1 156 157 158 159 160 1502